Océanie · Marchés régionaux · The Motley Fool Australia

Do I still rate CSL shares as a buy after rising 120% in four months?

Publié par The Motley Fool Australia · Australie il y a 1 h

Let's see if it is too late to buy this biotech giant's shares. The post Do I still rate CSL shares as a buy after rising 120% in four months? appeared first on The Motley Fool…

Lire l'article complet sur The Motley Fool Australia Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com.au)

Do I still rate CSL shares as a buy after rising 120% in four months?

À lire aussi

What David Jones can teach small business owners about letting go

Morning Headlines

The hidden risk of being the one who handles the money

Regional areas suffer from 'buyer's market with no buyers'

The AI bubble just burst. Here’s what it means for NZ – Liam Dann

ChartWatch ASX Scans: Wisetech Global, Pro Medicus, Domino's Pizza, Metcash, Neuren Pharmaceuticals, Temple & Webster

Do I still rate CSL shares as a buy after rising 120% in four months?

Partager

À lire aussi

What David Jones can teach small business owners about letting go

Morning Headlines

The hidden risk of being the one who handles the money

Regional areas suffer from 'buyer's market with no buyers'

The AI bubble just burst. Here’s what it means for NZ – Liam Dann

ChartWatch ASX Scans: Wisetech Global, Pro Medicus, Domino's Pizza, Metcash, Neuren Pharmaceuticals, Temple & Webster